InvestorsHub Logo
Followers 3
Posts 191
Boards Moderated 0
Alias Born 04/19/2006

Re: BioBS2012 post# 150887

Tuesday, 12/03/2013 12:16:25 PM

Tuesday, December 03, 2013 12:16:25 PM

Post# of 346136
Comparable Company Analysis disprove your Masterpieces take time analogy. Apples to Apples, PPHM is junk. The point is that valuations in biotechnology are supposed to mean something. Valuations are intended to reflect data, peak sales potential, and a company's likelihood of an eventual FDA approval. The higher the valuation, the higher the expectations and vice versa.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News